SCHEMBL4805629

SCHEMBL4805629

CCN(CC)CCOCCOC(=O)N1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
CHRM2 P08172 6/20 0.41
CHRM1 P11229 6/20 0.41
LMNA P02545 3/20 0.41
TSHR P16473 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
HTT P42858 2/20 0.41
SLC22A1 O15245 1/20 0.41
THRB P10828 1/20 0.41
PRCP P42785 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
BCHE P06276 1/20 0.36
PMP22 Q01453 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23094386 0.83 POLB (0.44) KDM4ELMNATSHRALDH1A1HTT
SCHEMBL22672640 0.80 MEN1 (0.40) LMNATSHRALDH1A1HTTPOLB
SCHEMBL22838001 0.80 ALDH1A1 (0.44) CHRM2CHRM1LMNATSHRALDH1A1
SCHEMBL14415917 0.79 KMT2A (0.38) KDM4ELMNATSHRALDH1A1TDP1
SCHEMBL24234390 0.78 POLB (0.36) LMNATSHRALDH1A1HTTPOLB
SCHEMBL22672756 0.77 CA2 (0.36) KDM4ELMNATSHRALDH1A1TDP1
SCHEMBL20844330 0.77 SMN1; SMN2 (0.38) LMNATSHRALDH1A1HTTPOLB
SCHEMBL952311 0.76 POLB (0.49) KDM4ELMNATSHRALDH1A1TDP1
SCHEMBL27670388 0.75 CHRNB2 (0.44) CHRM2CHRM1LMNATSHRPOLB
SCHEMBL16599995 0.75 MEN1 (0.43) LMNATSHRALDH1A1HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed